|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
CA2853412C
(en)
*
|
2011-10-28 |
2021-05-04 |
University Of Zurich |
Tdp-43 specific binding molecules
|
|
CN105593240B
(zh)
*
|
2013-06-11 |
2024-05-31 |
保罗·谢勒学院 |
用于以单氨基酸分辨率确定可突变配体-gpcr结合的方法以及突变配体和gpcr对
|
|
EP3099712A4
(en)
|
2014-01-31 |
2017-11-08 |
Arizona Board of Regents on behalf of Arizona State University |
Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein tdp-43
|
|
EP3174898A2
(en)
|
2014-07-29 |
2017-06-07 |
Neurimmune Holding AG |
Human-derived anti-huntingtin (htt) antibodies and uses thereof
|
|
CN104497121A
(zh)
*
|
2014-08-29 |
2015-04-08 |
苏州顺升桥生物科技有限公司 |
淀粉样蛋白tdp-43及其用途
|
|
WO2016053610A1
(en)
*
|
2014-10-03 |
2016-04-07 |
Academia Sinica |
Antibodies against pathological forms of tdp-43 and uses thereof
|
|
JP2018503596A
(ja)
|
2014-10-03 |
2018-02-08 |
アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ |
Ｔｄｐ−４３の病理学的形態に対する抗体及びその使用
|
|
TWI592423B
(zh)
*
|
2014-10-03 |
2017-07-21 |
中央研究院 |
可辨識致病性ｔｄｐ－４３之抗體及其用途
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
US10509045B2
(en)
|
2015-05-29 |
2019-12-17 |
University Of Florida Research Foundation, Incorporated |
Methods for diagnosing Huntington's disease
|
|
WO2017111166A1
(ja)
*
|
2015-12-25 |
2017-06-29 |
国立大学法人東京農工大学 |
Ｔｄｐ－４３細胞内存在量関連疾患治療剤
|
|
PL3430397T3
(pl)
|
2016-03-14 |
2022-04-04 |
Biogen International Neuroscience Gmbh |
Oznaczenie fagocytozy zależnej od przeciwciał do wiarygodnych pomiarów wychwytu zagregowanych białek
|
|
US10940161B2
(en)
|
2016-04-04 |
2021-03-09 |
University Of Florida Research Foundation, Incorporated |
Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
|
|
MA45715A
(fr)
|
2016-07-25 |
2019-05-29 |
Biogen Ma Inc |
Anticorps anti-hspa5 (grp78) et leurs utilisations
|
|
US20200031895A1
(en)
|
2016-12-16 |
2020-01-30 |
Biogen Ma Inc. |
Stabilized proteolytically activated growth differentiation factor 11
|
|
PE20250933A1
(es)
|
2017-03-14 |
2025-04-02 |
Five Prime Therapeutics Inc |
Anticuerpos de union a vista a ph acido
|
|
EP3612190A4
(en)
|
2017-04-17 |
2021-01-20 |
University of Florida Research Foundation, Incorporated |
REGULATION OF RAN TRANSLATION THROUGH PKR AND EIF2A-P WAYS
|
|
JP7761373B2
(ja)
*
|
2017-05-30 |
2025-10-28 |
ザ ユニヴァーシティ オブ ブリティッシュ コロンビア |
Ｔｄｐ－４３のｒｎａ認識モチーフ１（ｒｒｍ１）中のエピトープ、およびそれらに対するミスフォールディング選択的抗体
|
|
MD3672631T3
(ro)
|
2017-08-22 |
2023-09-30 |
Biogen Ma Inc |
Compoziții farmaceutice conținând anticorpi anti-beta amiloidici
|
|
EP3688020A4
(en)
|
2017-09-25 |
2021-07-14 |
University of Florida Research Foundation, Incorporated |
IMMUNOASSAYS FOR DETECTION OF RAN PROTEINS
|
|
AU2018342105B2
(en)
|
2017-09-26 |
2023-11-16 |
University Of Florida Research Foundation, Incorporated |
Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders
|
|
WO2019113711A1
(en)
|
2017-12-14 |
2019-06-20 |
University Of Ottawa |
Exosome packaging and targeted autophagy
|
|
WO2019118527A1
(en)
*
|
2017-12-14 |
2019-06-20 |
The Johns Hopkins University |
Novel anti-fungal inhibitors
|
|
US11466077B2
(en)
|
2018-01-05 |
2022-10-11 |
Ac Immune Sa |
Misfolded TDP-43 binding molecules
|
|
JP7320282B2
(ja)
*
|
2018-03-16 |
2023-08-03 |
国立大学法人滋賀医科大学 |
異常ｔｄｐ－４３を分解除去する抗体断片
|
|
SG11202008593PA
(en)
|
2018-03-21 |
2020-10-29 |
Five Prime Therapeutics Inc |
ANTIBODIES BINDING TO VISTA AT ACIDIC pH
|
|
TW202019398A
(zh)
*
|
2018-06-28 |
2020-06-01 |
張翔毓 |
用於治療或預防構形疾病之方法及藥物篩選方法
|
|
AU2019301120A1
(en)
|
2018-07-11 |
2021-02-25 |
Bristol-Myers Squibb Company |
Antibodies binding to VISTA at acidic pH
|
|
MA54070A
(fr)
|
2018-10-29 |
2021-09-08 |
Biogen Ma Inc |
Variants fc5 humanisés et stabilisés pour l'amélioration du transport à travers la barrière hémato-encéphalique
|
|
AU2019399680B2
(en)
*
|
2018-12-14 |
2026-07-23 |
Promis Neurosciences Inc. |
Antibodies to misfolded TDP-43 and methods of use
|
|
CN114008073B
(zh)
*
|
2019-05-23 |
2025-08-12 |
Ac免疫有限公司 |
抗tdp-43结合分子及其用途
|
|
AU2020331401B2
(en)
*
|
2019-08-12 |
2025-04-24 |
Celosia Therapeutics Pty Ltd |
Compositions and methods for treatment
|
|
AU2020348916B2
(en)
|
2019-09-20 |
2025-12-18 |
University Of Florida Research Foundation, Incorporated |
Detection of antibodies against RAN proteins from serum and tissue lysates
|
|
WO2021072187A2
(en)
|
2019-10-10 |
2021-04-15 |
University Of Florida Research Foundation, Incorporated |
Ran proteins as biomarkers in cag/ctg expansion disorders
|
|
GB202004863D0
(en)
*
|
2020-04-02 |
2020-05-20 |
Univ Oxford Innovation Ltd |
Method
|
|
JP7894321B2
(ja)
|
2020-04-28 |
2026-07-23 |
ソラ・バイオサイエンシズ・エルエルシー |
Ｔｄｐ－４３プロテイノパチーの処置のための組成物および方法
|
|
KR20230003067A
(ko)
*
|
2020-04-29 |
2023-01-05 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
미스폴딩된 tdp-43에 대한 단일쇄 항체 및 인트라바디 그리고 사용 방법
|
|
US20230288432A1
(en)
*
|
2020-07-06 |
2023-09-14 |
The Board Of Regents Of The University Of Texas System |
Tdp-43 biosensor cell lines
|
|
CN116615452A
(zh)
*
|
2020-08-14 |
2023-08-18 |
Ac免疫有限公司 |
人源化抗tdp-43结合分子及其用途
|
|
WO2022115705A2
(en)
|
2020-11-30 |
2022-06-02 |
Enigma Biointelligence, Inc. |
Non-invasive assessment of alzheimer's disease
|
|
WO2022164288A1
(ko)
|
2021-01-29 |
2022-08-04 |
한국과학기술원 |
비염증성 식세포작용 유도 활성을 갖는 융합분자
|
|
CN112920264B
(zh)
*
|
2021-02-08 |
2022-07-05 |
武汉大学 |
Tdp-43蛋白的o-糖基化突变体及其应用
|
|
JP6961278B1
(ja)
*
|
2021-03-10 |
2021-11-05 |
国立研究開発法人量子科学技術研究開発機構 |
生体試料中のｔｄｐ−４３を測定する方法及び装置
|
|
CA3221254A1
(en)
*
|
2021-05-27 |
2022-12-01 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating proteinopathies
|
|
CA3231484A1
(en)
|
2021-10-01 |
2023-04-06 |
Qinwen Mao |
Pathologic tdp-43 as a biomarker for the diagnosis of tdp-43 proteinopathy
|
|
CA3239708A1
(en)
|
2021-12-03 |
2023-06-08 |
Aubin MICHALON |
Novel potency assay for antibody-based drugs and useful means therefor
|
|
AU2023221539A1
(en)
|
2022-02-16 |
2024-08-22 |
Ac Immune Sa |
Humanized anti-tdp-43 binding molecules and uses thereof
|
|
IL316153A
(en)
*
|
2022-04-08 |
2024-12-01 |
Ac Immune Sa |
Anti-tdp-43 binding molecules
|
|
WO2023205579A1
(en)
*
|
2022-04-18 |
2023-10-26 |
The Regents Of The University Of California |
Compositions and methods for disrupting pathological aggregates
|
|
EP4497826A4
(en)
|
2022-04-22 |
2026-03-25 |
Univ Niigata |
TDP-43 AGGREGATION SUPPRESSANT AND PHARMACEUTICAL COMPOSITION
|
|
WO2024184494A1
(en)
|
2023-03-08 |
2024-09-12 |
Ac Immune Sa |
Anti-tdp-43 binding molecules and uses thereof
|
|
WO2024263701A1
(en)
*
|
2023-06-20 |
2024-12-26 |
The Trustees Of Dartmouth College |
Chimeric antigen receptors (cars) targeting tdp43, tregs expressing said cars, and use thereof for the treatment of als, ftd and ad
|
|
KR102859015B1
(ko)
*
|
2023-07-20 |
2025-09-12 |
충북대학교 산학협력단 |
ｃＡｂｌ에 의한 ＴＤＰ４３의 특이적 인산화 분석을 통한 신경퇴행성 질환을 진단하는 방법 및 이를 이용한 신경퇴행성 질환의 치료제 스크리닝 방법
|
|
CN116875738A
(zh)
*
|
2023-07-24 |
2023-10-13 |
山东省农业科学院畜牧兽医研究所 |
一种鉴定牛tdp-43基因启动子活性区域的方法
|
|
WO2025059486A1
(en)
*
|
2023-09-15 |
2025-03-20 |
Prothena Biosciences Limited |
Anti-tdp-43 antibodies and uses thereof
|
|
WO2025186332A1
(en)
|
2024-03-05 |
2025-09-12 |
Ac Immune Sa |
Vectorized anti-tdp-43 antibodies
|
|
WO2026013218A1
(en)
|
2024-07-10 |
2026-01-15 |
Ac Immune Sa |
Anti-tdp-43 vectors, binding molecules and uses thereof
|
|
KR20260044274A
(ko)
*
|
2024-09-23 |
2026-04-02 |
주식회사 피플바이오 |
Tdp-43에 특이적으로 결합하는 항체 및 이의 용도
|
|
CN119331085B
(zh)
*
|
2024-10-16 |
2025-03-14 |
中国科学院合肥物质科学研究院 |
沙贝冠状病毒广谱中和抗体及其应用
|
|
WO2026132413A1
(en)
|
2024-12-20 |
2026-06-25 |
Bioarctic Ab |
Antibody against tdp-43
|
|
EP4775993A1
(en)
*
|
2025-01-13 |
2026-07-15 |
Fundación Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA-Nanociencia) |
Assay for tdp-43 determination
|
|
EP4781999A1
(en)
|
2025-01-24 |
2026-07-29 |
Brainever |
Engrailed protein for use in the treatment of tdp-43 proteinopathies
|